Genitourinary Cancers Treatment Market, Global Outlook and Forecast 2022-2028

July 2024 | 65 pages | ID: G407F374081CEN
Market Monitor Global

Abstracts

Genitourinary cancers treatment pertains to the drugs used to cure or halt progress of cancers found in the urinary and the reproductive system, which include prostate cancer, kidney cancer, bladder cancer, testicular cancer and cancers of the penis. Genitourinary cancers treatment is a specialised branch of oncology that deals with the urinary and the reproductive systems.

This report contains market size and forecasts of Genitourinary Cancers Treatment in Global, including the following market information:

Global Genitourinary Cancers Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Genitourinary Cancers Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Genitourinary Cancers Treatment include Roche Holding, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Pfizer, Merck & Company, AbbVie and AstraZeneca and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Genitourinary Cancers Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Genitourinary Cancers Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Genitourinary Cancers Treatment Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy
• Radiotherapy
• Others

Global Genitourinary Cancers Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Genitourinary Cancers Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Cancer Clinics
• Others

Global Genitourinary Cancers Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Genitourinary Cancers Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Genitourinary Cancers Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Genitourinary Cancers Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche Holding
• Celgene
• Novartis
• Bristol-Myers Squibb
• Johnson & Johnson
• Pfizer
• Merck & Company
• AbbVie
• AstraZeneca
• Eli Lilly

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Genitourinary Cancers Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Genitourinary Cancers Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENITOURINARY CANCERS TREATMENT OVERALL MARKET SIZE

2.1 Global Genitourinary Cancers Treatment Market Size: 2021 VS 2028
2.2 Global Genitourinary Cancers Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Genitourinary Cancers Treatment Players in Global Market
3.2 Top Global Genitourinary Cancers Treatment Companies Ranked by Revenue
3.3 Global Genitourinary Cancers Treatment Revenue by Companies
3.4 Top 3 and Top 5 Genitourinary Cancers Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Genitourinary Cancers Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genitourinary Cancers Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Genitourinary Cancers Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Genitourinary Cancers Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Genitourinary Cancers Treatment Market Size Markets, 2021 & 2028
  4.1.2 Chemotherapy
  4.1.3 Radiotherapy
  4.1.4 Others
4.2 By Type - Global Genitourinary Cancers Treatment Revenue & Forecasts
  4.2.1 By Type - Global Genitourinary Cancers Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Genitourinary Cancers Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Genitourinary Cancers Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Genitourinary Cancers Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Cancer Clinics
  5.1.4 Others
5.2 By Application - Global Genitourinary Cancers Treatment Revenue & Forecasts
  5.2.1 By Application - Global Genitourinary Cancers Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Genitourinary Cancers Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Genitourinary Cancers Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Genitourinary Cancers Treatment Market Size, 2021 & 2028
6.2 By Region - Global Genitourinary Cancers Treatment Revenue & Forecasts
  6.2.1 By Region - Global Genitourinary Cancers Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Genitourinary Cancers Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Genitourinary Cancers Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Genitourinary Cancers Treatment Revenue, 2017-2028
  6.3.2 US Genitourinary Cancers Treatment Market Size, 2017-2028
  6.3.3 Canada Genitourinary Cancers Treatment Market Size, 2017-2028
  6.3.4 Mexico Genitourinary Cancers Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Genitourinary Cancers Treatment Revenue, 2017-2028
  6.4.2 Germany Genitourinary Cancers Treatment Market Size, 2017-2028
  6.4.3 France Genitourinary Cancers Treatment Market Size, 2017-2028
  6.4.4 U.K. Genitourinary Cancers Treatment Market Size, 2017-2028
  6.4.5 Italy Genitourinary Cancers Treatment Market Size, 2017-2028
  6.4.6 Russia Genitourinary Cancers Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Genitourinary Cancers Treatment Market Size, 2017-2028
  6.4.8 Benelux Genitourinary Cancers Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Genitourinary Cancers Treatment Revenue, 2017-2028
  6.5.2 China Genitourinary Cancers Treatment Market Size, 2017-2028
  6.5.3 Japan Genitourinary Cancers Treatment Market Size, 2017-2028
  6.5.4 South Korea Genitourinary Cancers Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Genitourinary Cancers Treatment Market Size, 2017-2028
  6.5.6 India Genitourinary Cancers Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Genitourinary Cancers Treatment Revenue, 2017-2028
  6.6.2 Brazil Genitourinary Cancers Treatment Market Size, 2017-2028
  6.6.3 Argentina Genitourinary Cancers Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Genitourinary Cancers Treatment Revenue, 2017-2028
  6.7.2 Turkey Genitourinary Cancers Treatment Market Size, 2017-2028
  6.7.3 Israel Genitourinary Cancers Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Genitourinary Cancers Treatment Market Size, 2017-2028
  6.7.5 UAE Genitourinary Cancers Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche Holding
  7.1.1 Roche Holding Corporate Summary
  7.1.2 Roche Holding Business Overview
  7.1.3 Roche Holding Genitourinary Cancers Treatment Major Product Offerings
  7.1.4 Roche Holding Genitourinary Cancers Treatment Revenue in Global Market (2017-2022)
  7.1.5 Roche Holding Key News
7.2 Celgene
  7.2.1 Celgene Corporate Summary
  7.2.2 Celgene Business Overview
  7.2.3 Celgene Genitourinary Cancers Treatment Major Product Offerings
  7.2.4 Celgene Genitourinary Cancers Treatment Revenue in Global Market (2017-2022)
  7.2.5 Celgene Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Genitourinary Cancers Treatment Major Product Offerings
  7.3.4 Novartis Genitourinary Cancers Treatment Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Genitourinary Cancers Treatment Major Product Offerings
  7.4.4 Bristol-Myers Squibb Genitourinary Cancers Treatment Revenue in Global Market (2017-2022)
  7.4.5 Bristol-Myers Squibb Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson Genitourinary Cancers Treatment Major Product Offerings
  7.5.4 Johnson & Johnson Genitourinary Cancers Treatment Revenue in Global Market (2017-2022)
  7.5.5 Johnson & Johnson Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Genitourinary Cancers Treatment Major Product Offerings
  7.6.4 Pfizer Genitourinary Cancers Treatment Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News
7.7 Merck & Company
  7.7.1 Merck & Company Corporate Summary
  7.7.2 Merck & Company Business Overview
  7.7.3 Merck & Company Genitourinary Cancers Treatment Major Product Offerings
  7.7.4 Merck & Company Genitourinary Cancers Treatment Revenue in Global Market (2017-2022)
  7.7.5 Merck & Company Key News
7.8 AbbVie
  7.8.1 AbbVie Corporate Summary
  7.8.2 AbbVie Business Overview
  7.8.3 AbbVie Genitourinary Cancers Treatment Major Product Offerings
  7.8.4 AbbVie Genitourinary Cancers Treatment Revenue in Global Market (2017-2022)
  7.8.5 AbbVie Key News
7.9 AstraZeneca
  7.9.1 AstraZeneca Corporate Summary
  7.9.2 AstraZeneca Business Overview
  7.9.3 AstraZeneca Genitourinary Cancers Treatment Major Product Offerings
  7.9.4 AstraZeneca Genitourinary Cancers Treatment Revenue in Global Market (2017-2022)
  7.9.5 AstraZeneca Key News
7.10 Eli Lilly
  7.10.1 Eli Lilly Corporate Summary
  7.10.2 Eli Lilly Business Overview
  7.10.3 Eli Lilly Genitourinary Cancers Treatment Major Product Offerings
  7.10.4 Eli Lilly Genitourinary Cancers Treatment Revenue in Global Market (2017-2022)
  7.10.5 Eli Lilly Key News

8 CONCLUSION


9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Genitourinary Cancers Treatment Market Opportunities & Trends in Global Market
Table 2. Genitourinary Cancers Treatment Market Drivers in Global Market
Table 3. Genitourinary Cancers Treatment Market Restraints in Global Market
Table 4. Key Players of Genitourinary Cancers Treatment in Global Market
Table 5. Top Genitourinary Cancers Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Genitourinary Cancers Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Genitourinary Cancers Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Genitourinary Cancers Treatment Product Type
Table 9. List of Global Tier 1 Genitourinary Cancers Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genitourinary Cancers Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Genitourinary Cancers Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Genitourinary Cancers Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Genitourinary Cancers Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Genitourinary Cancers Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Genitourinary Cancers Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Genitourinary Cancers Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Genitourinary Cancers Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Genitourinary Cancers Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Genitourinary Cancers Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Genitourinary Cancers Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Genitourinary Cancers Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Genitourinary Cancers Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Genitourinary Cancers Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Genitourinary Cancers Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Roche Holding Corporate Summary
Table 31. Roche Holding Genitourinary Cancers Treatment Product Offerings
Table 32. Roche Holding Genitourinary Cancers Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corporate Summary
Table 34. Celgene Genitourinary Cancers Treatment Product Offerings
Table 35. Celgene Genitourinary Cancers Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Genitourinary Cancers Treatment Product Offerings
Table 38. Novartis Genitourinary Cancers Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Genitourinary Cancers Treatment Product Offerings
Table 41. Bristol-Myers Squibb Genitourinary Cancers Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Genitourinary Cancers Treatment Product Offerings
Table 44. Johnson & Johnson Genitourinary Cancers Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Genitourinary Cancers Treatment Product Offerings
Table 47. Pfizer Genitourinary Cancers Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Merck & Company Corporate Summary
Table 49. Merck & Company Genitourinary Cancers Treatment Product Offerings
Table 50. Merck & Company Genitourinary Cancers Treatment Revenue (US$, Mn), (2017-2022)
Table 51. AbbVie Corporate Summary
Table 52. AbbVie Genitourinary Cancers Treatment Product Offerings
Table 53. AbbVie Genitourinary Cancers Treatment Revenue (US$, Mn), (2017-2022)
Table 54. AstraZeneca Corporate Summary
Table 55. AstraZeneca Genitourinary Cancers Treatment Product Offerings
Table 56. AstraZeneca Genitourinary Cancers Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Eli Lilly Corporate Summary
Table 58. Eli Lilly Genitourinary Cancers Treatment Product Offerings
Table 59. Eli Lilly Genitourinary Cancers Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Genitourinary Cancers Treatment Segment by Type in 2021
Figure 2. Genitourinary Cancers Treatment Segment by Application in 2021
Figure 3. Global Genitourinary Cancers Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Genitourinary Cancers Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Genitourinary Cancers Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genitourinary Cancers Treatment Revenue in 2021
Figure 8. By Type - Global Genitourinary Cancers Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Genitourinary Cancers Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Genitourinary Cancers Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Genitourinary Cancers Treatment Revenue Market Share, 2017-2028
Figure 12. US Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Genitourinary Cancers Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Genitourinary Cancers Treatment Revenue Market Share, 2017-2028
Figure 24. China Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Genitourinary Cancers Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Genitourinary Cancers Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Genitourinary Cancers Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Holding Genitourinary Cancers Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Genitourinary Cancers Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Genitourinary Cancers Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Genitourinary Cancers Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Genitourinary Cancers Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Genitourinary Cancers Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck & Company Genitourinary Cancers Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AbbVie Genitourinary Cancers Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. AstraZeneca Genitourinary Cancers Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eli Lilly Genitourinary Cancers Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)